What is InsiderStreet.ai?

InsiderStreet.ai is a free financial intelligence platform tracking smart-money signals — insider trades, congressional stock disclosures, hedge fund positions, ETF flows, dark pool activity, and short interest — across 88,000+ securities.

How do I track which hedge funds own a stock?

On any stock page on InsiderStreet, the Hedge Fund Holders tab shows every fund holding that stock — names, position size, quarterly changes, and fund flows. Data is sourced from SEC institutional ownership disclosures.

How do I see which Congress members trade a stock?

Each stock page has a Smart Money tab that shows congressional disclosures under the STOCK Act — senators and representatives, transaction type, date, and dollar range — typically disclosed within 45 days of the trade.

ZTS vs TEVA vs VTRS

161 measures in 16 categories, one definition each, computed from filings and market data.

ZTS66.0

Zoetis Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$79.32 +1.20%$32.8B mkt cap

Score DNA

TEVA40.1

Teva Pharmaceutical Industries Limited

Healthcare · Drug Manufacturers - Specialty & Generic

$41.50 +0.95%$48.4B mkt cap

Score DNA

VTRS37.1

Viatris Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$18.66 +2.41%$21.4B mkt cap

Score DNA

Price, rebased to 100 three years ago

ZTS TEVA VTRS · weekly adjusted closes

Smart money 8 Valuation 16 Profitability (TTM) 12 Returns on capital 11 Growth 17 Margin history & stability 7 Liquidity (latest quarter) 7 Leverage & solvency (latest quarter) 13 Efficiency 11 Cash flow & earnings quality 7 Dividends & buybacks 9 Scores & forensic checks 15 Per share 7 Size (TTM) 8 Price performance 9 Technicals 4

● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures

Measure	ZTS	TEVA	VTRS
Insider open-market buys, 180d	3	0	0
Insider $ bought, 180d	$0.89M	—	—
Congress purchases, 180d	16	0	0
Last Congress purchase	2026-09-18	—	—
13F net change in holders	—	—	+8
ETFs adding shares, 30d	1,343	161	637
ETFs trimming, 30d	1,138	107	594
Net ETF funds, 30d	+205	+54	+43

Valuation

16 measures

Measure	ZTS	TEVA	VTRS
P/E (TTM)	12.5x 20th	68.5x 80th	—
PEG (P/E ÷ 3-yr EPS CAGR)	1.33	—	—
Price / sales	3.4x 64th	2.8x 57th	1.5x 21st
Price / book	10.4x 86th	6.2x 81st	1.5x 24th
Price / tangible book	—	—	—
Price / free cash flow	13.9x 45th	35.9x 75th	11.4x 35th
Price / operating cash flow	11.4x 45th	25.5x 75th	9.2x 40th
Enterprise value	$40.3B 96th	$61.6B 100th	$33.5B 93rd
EV / sales	4.2x 75th	3.6x 68th	2.3x 50th
EV / EBITDA	10.1x 39th	23.7x 78th	12.3x 50th
EV / EBIT	11.5x 27th	38.4x 73rd	—
EV / free cash flow	17.0x 50th	45.7x 75th	17.9x 55th
Earnings yield	8.0% 89th	1.5% 57th	-1.9% 39th
FCF yield	7.2% 68th	2.8% 46th	8.7% 75th
Operating cash flow yield	8.8% 68th	3.9% 46th	10.9% 71st
Graham number (per share)	$32.59 85th	$9.40 31st	—

Profitability (TTM)

12 measures

Measure	ZTS	TEVA	VTRS
Gross margin	70.9% 75th	52.5% 39th	34.8% 18th
EBITDA margin	42.0% 93rd	15.0% 46th	18.4% 61st
Operating margin	37.0% 96th	11.5% 57th	-0.6% 21st
EBIT margin	36.9% 96th	9.3% 57th	-0.6% 39th
Net margin	27.5% 89th	4.1% 54th	-2.8% 43rd
NOPAT margin	29.6% 93rd	11.3% 61st	-0.5% 21st
FCF margin	24.9% 89th	7.8% 50th	12.7% 57th
Operating cash flow margin	30.3% 93rd	11.0% 46th	15.8% 64th
R&D / revenue	7.6% 64th	5.7% 39th	6.9% 54th
SG&A / revenue	25.0% 39th	23.8% 36th	27.0% 43rd
Stock comp / revenue	1.0% 19th	1.0% 15th	1.2% 23rd
Effective tax rate	20.0% 29th	1.7% 11th	21.0% 32nd

Returns on capital

11 measures

Measure	ZTS	TEVA	VTRS
ROE (on average equity)	64.4% 100th	9.7% 60th	-2.8% 35th
ROA	17.7% 89th	1.8% 50th	-1.1% 43rd
ROIC	26.3% 86th	9.3% 54th	-0.3% 18th
ROCE	27.0% 93rd	6.6% 61st	-0.3% 36th
Return on tangible assets	23.8% 93rd	4.0% 57th	-0.2% 39th
Cash ROIC (OCF / invested capital)	27.0% 81st	9.0% 50th	8.8% 46th
Gross profitability (GP / assets)	44.7% 75th	22.8% 43rd	14.6% 11th
ROIC, 3-yr average	21.5% 91st	2.3% 52nd	-3.7% 30th
ROIC, 5-yr average	23.2% 84th	-0.9% 37th	-1.6% 26th
ROE, 5-yr average	55.3% 100th	-8.8% 30th	-3.1% 50th
Incremental ROIC	117.6% 86th	749.2% 100th	-109.4% 11th

Growth

17 measures

Measure	ZTS	TEVA	VTRS
Revenue growth (TTM YoY)	1.4% 25th	4.1% 32nd	4.4% 36th
Revenue growth (QoQ)	9.1% 61st	4.0% 32nd	6.8% 46th
Revenue CAGR, 3 yr	5.0% 36th	4.9% 32nd	-1.9% 11th
Revenue CAGR, 5 yr	5.1% 24th	1.2% 16th	-1.1% 8th
Gross profit CAGR, 3 yr	6.3% 20th	10.0% 44th	-6.0% 0th
Operating income CAGR, 3 yr	5.8% 23rd	—	—
Net income growth (TTM YoY)	0.2% 20th	—	—
Net income CAGR, 3 yr	5.7% 40th	—	—
EPS growth (TTM YoY)	6.8% 30th	—	—
EPS CAGR, 3 yr	9.4% 40th	—	—
EPS CAGR, 5 yr	9.4% 57th	—	—
FCF growth (TTM YoY)	6.6% 44th	9.6% 56th	10.5% 61st
FCF CAGR, 3 yr	22.6% 79th	4.7% 36th	-2.9% 29th
Operating cash flow CAGR, 3 yr	13.0% 62nd	3.8% 31st	-2.4% 19th
Book value CAGR, 3 yr	-9.0% 38th	1.4% 48th	-10.9% 33rd
Dividend CAGR, 3 yr	5.5% 80th	—	0.4% 60th
Sustainable growth rate	42.5% 92nd	9.7% 33rd	—

Margin history & stability

7 measures

Measure	ZTS	TEVA	VTRS
Gross margin, 3-yr average	69.7% 75th	50.5% 39th	37.5% 21st
Operating margin, 3-yr average	36.9% 96th	7.4% 57th	-6.4% 29th
Net margin, 3-yr average	27.2% 96th	0.1% 61st	-10.5% 32nd
FCF margin, 3-yr average	24.0% 89th	6.5% 43rd	12.4% 64th
Revenue stability (0-1)	0.97 89th	0.31 14th	0.59 21st
Earnings stability (0-1)	0.97 100th	0.79 93rd	0.04 14th
Margin stability (0-1)	0.98 86th	0.94 64th	0.86 29th

Liquidity (latest quarter)

7 measures

Measure	ZTS	TEVA	VTRS
Cash & short-term investments	$1.7B 93rd	$3.7B 100th	$1.5B 89th
Net cash (− = net debt)	−$7.6B 11th	−$13.2B 4th	−$12.1B 7th
Working capital	$4.3B 100th	−$1.9B 0th	$3.7B 96th
Current ratio	3.08 71st	0.88 4th	1.58 18th
Quick ratio	1.84 54th	0.67 4th	0.96 18th
Cash ratio (cash + ST investments / current liabilities)	0.81 50th	0.23 7th	0.24 11th
Defensive interval (days)	368 days 43rd	368 days 39th	362 days 32nd

Leverage & solvency (latest quarter)

13 measures

Measure	ZTS	TEVA	VTRS
Total debt	$9.2B 89th	$16.9B 96th	$13.6B 93rd
Debt / equity	2.93 90th	2.18 81st	0.96 62nd
Net debt / equity	2.40 90th	1.70 76th	0.85 62nd
Debt / assets	61.3% 75th	42.3% 57th	38.9% 43rd
Debt / capital	74.6% 90th	68.5% 81st	48.9% 62nd
Debt / EBITDA	2.31 39th	6.51 78th	5.02 67th
Net debt / EBITDA	1.89 50th	5.10 89th	4.46 83rd
Interest coverage (EBIT / interest)	14.4x 88th	1.8x 54th	−0.2x 38th
Cash interest coverage	11.8x 88th	2.1x 54th	4.9x 65th
Debt payback (years of OCF)	3.2 yrs 45th	8.9 yrs 75th	5.8 yrs 55th
Liabilities / assets	79.1% 61st	80.5% 64th	59.3% 39th
IS credit model rating	AA	B-	B
Implied credit spread (bps)	80 11th	900 75th	750 64th

Efficiency

11 measures

Measure	ZTS	TEVA	VTRS
Asset turnover	0.64 68th	0.43 32nd	0.40 21st
Fixed asset turnover	2.36 18th	4.06 29th	5.46 54th
Inventory turnover	1.1 15th	2.4 67th	2.3 56th
Receivables turnover	6.1 89th	4.9 46th	5.5 61st
Days sales outstanding	60 days 11th	74 days 54th	67 days 39th
Days inventory outstanding	330 days 85th	149 days 33rd	156 days 44th
Days payables outstanding	63 days 50th	116 days 71st	49 days 29th
Cash conversion cycle (days)	326 days 96th	108 days 25th	174 days 46th
Capex / revenue	5.5% 93rd	3.2% 57th	3.1% 54th
Capex / depreciation	1.08 75th	0.56 64th	0.16 25th
Operating expense ratio	34.8% 29th	48.4% 57th	38.6% 36th

Cash flow & earnings quality

7 measures

Measure	ZTS	TEVA	VTRS
Operating cash flow / net income	1.10 27th	2.69 80th	—
FCF / net income	0.90 33rd	1.91 73rd	—
FCF / operating cash flow	82.0% 40th	71.0% 20th	80.4% 35th
Capex / operating cash flow	18.0% 60th	29.0% 80th	19.6% 65th
Accruals ratio	-1.8% 75th	-3.0% 64th	-7.5% 39th
Sloan accruals ratio	8.5% 82nd	-9.1% 32nd	-4.7% 46th
Earnings quality score (0-1)	1.00 73rd	1.00 73rd	—

Dividends & buybacks

9 measures

Measure	ZTS	TEVA	VTRS
Dividend yield	2.6% 93rd	0.0% 0th	2.6% 89th
Dividend per share (TTM)	$2.09 100th	$0.00 0th	$0.48 89th
Payout ratio (dividends / net income)	34.0% 93rd	0.0% 0th	—
Dividends / FCF	37.6% 85th	0.0% 0th	29.8% 80th
Dividend growth (YoY)	13.1% 60th	—	-1.3% 20th
Buyback yield	11.1% 100th	0.0% 0th	1.4% 75th
Shareholder yield (dividends + buybacks)	13.8% 100th	0.0% 0th	4.0% 79th
Share count change (YoY)	-6.2% 11th	1.7% 57th	-0.8% 29th
Buybacks, last 5 years	$9.0B 100th	$0 0th	$1.9B 96th

Scores & forensic checks

15 measures

Measure	ZTS	TEVA	VTRS
IS score	66 82nd	40 39th	37 36th
IS profitability	98 100th	27 46th	12 4th
IS growth	47 32nd	60 54th	71 68th
IS value	71 89th	27 21st	49 64th
IS momentum	66 50th	87 71st	68 54th
IS risk (safety)	100 86th	15 25th	15 25th
IS quality	68 71st	54 64th	48 39th
IS balance sheet	56 64th	21 7th	36 36th
IS earnings quality	76 100th	74 96th	43 32nd
IS cash flow	65 68th	55 64th	49 54th
Piotroski F-score (0-9)	6 54th	7 68th	7 68th
Altman Z-score	4.6 86th	0.8 29th	1.1 36th
Beneish M-score	−2.55 61st	−2.68 46th	−2.93 21st
Ohlson O-score	−7.32 36th	−6.92 43rd	−8.03 21st
IS credit score	85 89th	21 25th	26 29th

Per share

7 measures

Measure	ZTS	TEVA	VTRS
EPS, diluted (TTM)	$6.26 100th	$0.60 68th	−$0.35 39th
Book value per share	$7.54 57th	$6.57 46th	$12.26 75th
Tangible book per share	−$1.30 39th	−$9.79 11th	−$5.22 14th
Revenue per share	$22.78 79th	$14.66 64th	$12.67 57th
FCF per share	$5.66 89th	$1.14 61st	$1.61 71st
Operating cash flow per share	$6.91 93rd	$1.61 61st	$2.00 75th
Cash per share	$4.01 75th	$3.09 64th	$1.30 36th

Size (TTM)

8 measures

Measure	ZTS	TEVA	VTRS
Market cap	$32.8B 96th	$48.4B 100th	$21.4B 93rd
Revenue	$9.5B 89th	$17.3B 100th	$14.7B 96th
EBITDA	$4.0B 100th	$2.6B 93rd	$2.7B 96th
Net income	$2.6B 100th	$706.0M 96th	−$410.7M 7th
Free cash flow	$2.4B 100th	$1.3B 89th	$1.9B 96th
Total assets	$15.1B 89th	$39.9B 100th	$35.0B 96th
Shareholders' equity	$3.1B 89th	$7.8B 96th	$14.3B 100th
Employees	14,500 89th	32,008 100th	30,000 96th

Price performance

9 measures

Measure	ZTS	TEVA	VTRS
1 day	+1.2%	+0.9%	+2.4%
1 week	+6.1%	+1.0%	+5.8%
1 month	+8.7%	+5.9%	+8.9%
3 months	+4.2%	+33.9%	+9.8%
6 months	−34.9%	+28.1%	+27.1%
Year to date	−36.7%	+34.1%	+49.8%
1 year	−44.0%	+109.8%	+89.1%
3 years, cumulative	−54.0%	+359.1%	+113.5%
5 years, cumulative	−58.2%	+308.5%	+65.1%

Technicals

4 measures

Measure	ZTS	TEVA	VTRS
RSI 14	69.4	65.4	69.2
From 52-week high	−46.3%	−1.2%	−0.1%
From 52-week low	+15.4%	+120.4%	+90.4%
Beta	0.74	0.82	0.86

InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

ZTS vs TEVA vs VTRS

Price, rebased to 100 three years ago

Smart money

Valuation

Profitability (TTM)

Returns on capital

Growth

Margin history & stability

Liquidity (latest quarter)

Leverage & solvency (latest quarter)

Efficiency

Cash flow & earnings quality

Dividends & buybacks

Scores & forensic checks

Per share

Size (TTM)

Price performance

Technicals

Sign in to InsiderStreet